Diabetic ketoacidosis
50 results
1 - 50
Diabetic ketoacidosis 
Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis
Type 1 diabetes in fair to good control not associated with reduced school performance in children- Hyperglycaemic hyperosmolar syndrome
- Rhabdomyolysis
- Type 1 diabetes: treatment
- Low-dose insulin at least as good as standard doses in biochemical control of kids with DKA
- Continuous glucose monitoring systems for type 1 diabetes mellitus
- Continuous subcutaneous insulin infusion for type 1 diabetes
- Diarrhoea and vomiting in children
- Newly diagnosed type 1 diabetes in a child
- Follow-up of type 1 diabetes
- Diabetes: definition, differential diagnosis and classification
- Magnesium deficiency
- No benefit from screening for asymptomatic CAD in type 2 diabetes
- A child or adolescent with type 1 diabetes in primary health care
- Oral antidiabetic drugs and GLP-1 analogues
- Routine hospital admission versus out‐patient or home care in children at diagnosis of type 1 diabetes mellitus
- Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients
- Leucocytosis
- Blood gas analysis and acid-base balance
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
- Sotagliflozin reduces hospitalizations and urgent visits for heart failure, but has no mortality benefit (SCORED)
- Acute abdomen in the adult
- Hyperkalaemia
- Insulin pumps lower A1C more than multiple insulin doses in patients with type 2 DM (OpT2mise)
- SGLT2 inhibitors = little effect on glycemic control or all-cause mortality, but decrease CV deaths in older adults with T2DM plus heart failure
- Limited meta-analysis suggests SGLT2 inhibitors improve cardiovascular outcomes in patients with T2DM + atherosclerosis
- Dapagliflozin in high-risk T2DM reduces hospitalization for HF, but does not reduce death, MI, or stroke (DECLARE-TIMI 58)
- Enhanced glucose control for preventing and treating diabetic neuropathy in type 1 diabetes
- Chronic heart failure
- Glycaemic control for slowing the progression of microvascular complications in diabetes mellitus
- Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
- Continuous glucose monitoring systems for type 1 diabetes mellitus
- Limited SR demonstrates SGLT2 inhibitors improve outcomes in adults with heart failure
- Conservative (non-surgical) treatment of obesity
- Preoperative assessment